Oncological outcomes and locoregional recurrence after fluorescence guided surgery for axillary staging in early breast cancer: A single UK center experience
ICG with blue dye in SLNB achieved 98.5% detection, 0.9% axillary recurrence, offering a safe, effective alternative to radioisotopes.